Mark Identification
PRISM
Serial Number
88985144
Filing Date
Jan 25, 2019
Trademark by
Classification Information
Research and development of oligonucleotide drug delivery platforms for use in the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for targeted gene silencing
Computer and Scientific